Low ADAMTS1 expression inhibits neutrophil and macrophage infiltration by inhibiting the level of proinflammatory cytokines and macrophage migration in the early stage of aneurysm formation, indicating ADAMTS proteins regulation of the inflammatory response, which may be a new therapeutic target in the treatment of aneurysms [120,121]. This evidence concerns the gene ADAMTS1 and aneurysm.